PeptideStack
5.2kquestions
20kanswers
220users

My tirzepatide vial sat at 2–8 °C for three days — is testing worth it before use?

Asked 17 Jul 2026Modified 1 min agoViewed 5.2k times
17

The specifics, since they change the answer: tirzepatide · 2–8 °C · three days.

I would like to define my thresholds before I have a result, for obvious reasons.

I want a plan with explicit stopping rules, not just steps.

What is the minimum version of this that is still defensible?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
shareeditfollowflag
DC
askedDr_Idris_Coulibaly33k13717 Jul 2026
8Is the material lyophilised or already in solution? Completely different answer. – e_dziedzic 6 months ago
add a comment

5 Answers

Accepted answer first, then by votes
8

Accepted answer

Three days at 2–8 °C is about 3 refrigerated days of equivalent exposure. 2–8 °C is the condition the rule of thumb is anchored to, so it is the baseline rather than a multiplier: everything else in this thread is quoted relative to it. At 3 equivalent days a test is more likely to reassure you than to tell you something, which is a legitimate reason to run it and a poor reason to expect a finding. Either way, record the three days and the temperature now, while you still know them; an excursion you did not write down is an excursion you cannot interpret later.

The domestic leg after arrival is the part most often left in a warm hallway and least often worried about.

A single-use temperature logger costs a few pounds, records the whole journey and converts an argument into a record. If the history matters, this is the answer.

Once the parcel arrives, the domestic leg is the controllable part: get it into the refrigerator promptly rather than leaving it in a warm hallway for a day.

Solid-state stability of lyophilised peptides at ambient temperature is documented in formulation studies with residual moisture as the dominant variable.

The caveat is that a warm transit is survivable for a solid and materially different for a solution.

Buy a logger if you actually want to know. Everything else is inference.

shareimprove this answerflag
ZM
answered · acceptedzainab_mustafa21k2721 Jul 2026
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
12

The short version: a spent cold pack on arrival is expected, the solid does not mind, and the pack was never going to last twelve days.

A pack that arrived hard tells you about the last day of transit only, since it will have melted and, if the ambient dropped, partially refrozen.

Anything shipped in solution is a different risk category, because hydrolysis and deamidation proceed in the aqueous phase and are strongly temperature-dependent.

A cold pack tells you nothing about the eleven days before the last one.

The domestic leg is the part you control. Refrigerate it promptly.

shareimprove this answerflag
JW
answeredj_wierzbicki69k14827 Jul 2026
7

Answering this needs the transit duration and the ambient temperature, and then the arithmetic is straightforward.

A single phase-change pack in a thin-walled box holds below ten degrees for roughly one to two days at twenty-five degrees ambient, and under a day at thirty-five. On a nine-to-fourteen-day lane the material is at ambient for most of the journey whatever was packed with it.

That is the argument for shipping lyophilised rather than for shipping colder. A dry powder with low residual moisture is stable at ambient for months; the pathways that matter need water.

Single-use temperature loggers are standard practice in supply chains where temperature genuinely matters and are inexpensive at parcel scale.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Lyophilised tolerates the lane. That is the answer for almost every order.

shareimprove this answerflag
IB
answeredines_brandt113k25727 Jul 2026
5

The relevant detail is that this is where the anxiety in this hobby is most out of proportion to the chemistry.

Arrhenius behaviour means the degradation rate roughly doubles per ten degrees. A week at thirty degrees is therefore a meaningful exposure for a solution and an immaterial one for a dry solid.

Phase-change pack hold time is a function of mass, latent heat and insulation, and published figures for small parcels are on the order of one to two days.

Reconstituted material has a genuine cold-chain requirement and it starts the moment water is added.

A liquefied pack is expected. It is not evidence of a problem.

edited 17 Aug 2026 by esther_vandeVelde — added a caveat about sampling

shareimprove this answerflag
EV
answeredesther_vandeVelde52k2724 Jul 2026
3

The honest answer is that the cold pack is doing much less than people think and that shipping lyophilised is what actually protects the material.

Asking a supplier to hold a shipment during a heatwave is reasonable and the better ones agree; the cost is a week and the benefit is a shorter warm exposure for anything in solution.

Arrhenius kinetics predict approximately a doubling of degradation rate per ten-degree rise and are the standard basis for cold-chain design.

The caveat is that "within specification" and "unchanged" are different claims. A vial can lose a few per cent of content and still be usable for its purpose while no longer matching its certificate.

Solutions are a different question and deserve the worry the solids get.

shareimprove this answerflag
GA
answeredgrainne_ahearn50k3818 Jul 2026
2The doubling-per-ten-degrees rule is the part I did not know and now use constantly. – rota_site 8 months ago
3Aliquoting before the first freeze is the advice I wish I had read two years ago. – lyoph_cake 3 days ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.